Inventor · disambiguated record
Michael March Schmidt
Also filed as: GOETTING CHRISTIAN · SCHMIDT MICHAEL · SCHMIDT MICHAEL M · SCHMIDT MICHAEL MARCH
15 granted patents·14 pending applications·71 citations·filing 1999–2025
92Inventor score
Files withCOMPASS THERAPEUTICS LLC15ELEVEN BIOTHERAPEUTICS INC4ANKYRA THERAPEUTICS INC3SESEN BIO INC2ALBUMEDIX LTD1
Top patents by PatentIndex Score
29 records- 0196US10716851B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted Jul 21, 2020·10 cites·5 claims
- 0296US10350292B1Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2019·Granted Jul 16, 2019·12 cites·28 claims
- 0396US10279039B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted May 7, 2019·10 cites·20 claims
- 0496US10279038B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted May 7, 2019·11 cites·16 claims
- 0596US10279040B1Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2018·Granted May 7, 2019·10 cites·20 claims
- 0695US10434175B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2019·Granted Oct 8, 2019·5 cites·20 claims
- 0789US10711050B2Variant serum albumin with improved half-life and other propertiesALBUMEDIX LTD·Filed 2018·Granted Jul 14, 2020·6 cites·33 claims
- 0887US2024181050A1Agonist antibodies that bind human cd137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2023·Application pending·0 cites
- 0982US9951130B2IL-6 antagonists and uses thereofELEVEN BIOTHERAPEUTICS INC·Filed 2014·Granted Apr 24, 2018·7 cites·20 claims
- 1078US2020046833A1Agonist antibodies that bind human cd137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 1177US2025059270A1Il-6 antibodiesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1275US11752207B2Agonist antibodies that bind human CD137 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2020·Granted Sep 12, 2023·0 cites·13 claims
- 1372US2025327085A1Fusion polypeptidesANKYRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1469US12454695B2Fusion polypeptides comprising interleukin 12 and a metal-hydroxide binding polypeptideANKYRA THERAPEUTICS INC·Filed 2022·Granted Oct 28, 2025·0 cites·20 claims
- 1563US12467062B2Transgenic mouse expressing common human light chainCOMPASS THERAPEUTICS LLC·Filed 2019·Granted Nov 11, 2025·0 cites·26 claims
- 1661US2022169719A1Il-6 antibodiesSESEN BIO INC·Filed 2021·Application pending·0 cites
- 1757US11459386B2IL-6 antagonists and uses thereofELEVEN BIOTHERAPEUTICS INC·Filed 2018·Granted Oct 4, 2022·0 cites·10 claims
- 1855US2025339495A1Fusion polypeptides and formulations thereofANKYRA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1954US12460004B2Antibodies that bind CD277 and uses thereofCOMPASS THERAPEUTICS LLC·Filed 2019·Granted Nov 4, 2025·0 cites·12 claims
- 2052US2020079867A1Compositions and methods for enhancing the killing of target cells by nk cellsCOMPASS THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 2151US11142571B2IL-6 antibodiesSESEN BIO INC·Filed 2015·Granted Oct 12, 2021·0 cites·35 claims
- 2247US2014315817A1Variant serum albumin with improved half-life and other propertiesELEVEN BIOTHERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 2346US2016052993A1Albumin variants binding to fcrnELEVEN BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2445US2020109195A1Compositions and methods for enhancing the killing of target cells by nk cellsCOMPASS THERAPEUTICS LLC·Filed 2019·Application pending·0 cites
- 2543US2021388089A1Antigen binding agents that bind cd277 and uses thereofCONEJO GARCIA JOSE R·Filed 2019·Application pending·0 cites
- 2641US2019031785A1Multispecific immunomodulatory antigen-binding constructsCOMPASS THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
- 2738US2018318417A1Multispecific immunomodulatory antigen-binding constructsCOMPASS THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
- 2828US2013064788A1Il-17 family cytokine compositions and usesBARNES THOMAS M·Filed 2010·Application pending·0 cites
- 2915US6521410B1Mutant of tissue factor pathway inhibitor, DNA sequence and use for detecting thrombotic disordersKLEESIEK KNUT·Filed 1999·Granted Feb 18, 2003·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Michael March Schmidt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →